tiprankstipranks
Trending News
More News >

Innovative Pharmaceutical Biotech Expands into Thai Market with New Agency Agreement

Story Highlights
  • Innovative Pharmaceutical Biotech focuses on beauty equipment and oral insulin products.
  • The company signed a six-year agreement to market pancreatic health products in Thailand.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Innovative Pharmaceutical Biotech Expands into Thai Market with New Agency Agreement

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Innovative Pharmaceutical Biotech ( (HK:0399) ).

Innovative Pharmaceutical Biotech Limited announced that its subsidiary, Fosse Bio-Engineering Development Limited, has entered into an agency agreement with Terry Bio Pharmaceutical Co., Ltd. This agreement appoints Terry Bio Pharmaceutical as the exclusive agent to market, distribute, sell, and promote Fosse Bio-Engineering’s oral pancreatic health products in Thailand for a period of six years, with an automatic renewal for another six years. This strategic move aims to expand the company’s market presence in Thailand, contingent on obtaining necessary approvals by May 2025.

More about Innovative Pharmaceutical Biotech

Innovative Pharmaceutical Biotech Limited is an investment holding company primarily engaged in the trading of beauty equipment and products, as well as the research, development, and commercialization of oral insulin products.

YTD Price Performance: -13.94%

Average Trading Volume: 999,948

Technical Sentiment Consensus Rating: Buy

Current Market Cap: HK$326.2M

For detailed information about 0399 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1